Conference item
Guselkumab provides sustained domain-specific and comprehensive efficacy as assessed using composite endpoints in patients with active psoriatic arthritis free
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Authors
Bibliographic Details
- Publisher:
- BMJ Publishing Group Publisher's website
- Journal:
- Annals of the Rheumatic Diseases Journal website
- Volume:
- 80
- Pages:
- 781-782
- Publication date:
- 2021-05-19
- Acceptance date:
- 2021-04-01
- Event title:
- European Alliance of Associations for Rheumatology
- Event start date:
- 2021-06-02
- Event end date:
- 2021-06-05
- DOI:
- EISSN:
-
1468-2060
- ISSN:
-
0003-4967
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1195824
- Local pid:
- pubs:1195824
- Deposit date:
- 2021-10-04
Terms of use
- Copyright holder:
- Coates et al.
- Copyright date:
- 2021
- Rights statement:
- © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record